Search Results - "Meller, Simon T"
-
1
Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma
Published in Nuclear medicine communications (01-05-2016)“…OBJECTIVEIodine-131-labelled meta-iodobenzylguanidine (I-mIBG) therapy is an established treatment modality for relapsed/refractory neuroblastoma, most…”
Get full text
Journal Article -
2
Whole-Body Dosimetry for Individualized Treatment Planning of 131I-MIBG Radionuclide Therapy for Neuroblastoma
Published in The Journal of nuclear medicine (1978) (01-09-2009)“…The aims of this study were to examine the relationship between whole-body absorbed dose and hematologic toxicity and to assess the most accurate method of…”
Get full text
Journal Article -
3
Absorbed dose ratios for repeated therapy of neuroblastoma with I-131 mIBG
Published in Cancer biotherapy & radiopharmaceuticals (01-02-2003)“…Patients undergoing targeted radionuclide therapy (TRT) may receive a series of two or more treatment administrations at varying intervals. However, the level…”
Get more information
Journal Article -
4
Whole-Body Dosimetry for Individualized Treatment Planning of 131 I-MIBG Radionuclide Therapy for Neuroblastoma
Published in Journal of Nuclear Medicine (01-09-2009)Get full text
Journal Article -
5
Whole-Body Dosimetry for Individualized Treatment Planning of ^sup 131^I-MIBG Radionuclide Therapy for Neuroblastoma
Published in The Journal of nuclear medicine (1978) (01-09-2009)“…The aims of this study were to examine the relationship between whole-body absorbed dose and hematologic toxicity and to assess the most accurate method of…”
Get full text
Journal Article -
6
Acute leukaemia
Published in Medicine (Abingdon. 1995, UK ed.) (01-06-2004)“…The acute leukaemias are divided into two main groups, reflecting their cells of origin: • acute lymphoblastic (the blast cells arise from a committed lymphoid…”
Get full text
Journal Article -
7
Seizures and cortical dysfunction following high-dose cisplatin administration in children
Published in Medical and pediatric oncology (1992)“…Four of eight children with advanced neuroblastoma treated with a rapid delivery high dose intensity cisplatin based regimen developed acute neurological…”
Get more information
Journal Article -
8
Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma
Published in Cancer biotherapy & radiopharmaceuticals (01-04-2005)“…(131)I-meta iodobenzylguanidine ((131)I-mIBG) therapy is established palliation for relapsed neuroblastoma. The topoisomerase-1 inhibitor, topotecan, has…”
Get more information
Journal Article -
9
High-dose rapid schedule chemotherapy for disseminated neuroblastoma
Published in European journal of cancer (1990) (1992)“…In a high-dose schedule for disseminated neuroblastoma, eight courses of chemotherapy were administered every 10 days, regardless of myelosuppression, to…”
Get more information
Journal Article -
10
Quantitative Study of Radioiodinated Metaiodobenzylguanidine Uptake in Children with Neuroblastoma: Correlation with Tumor Histopathology
Published in The Journal of nuclear medicine (1978) (01-04-1989)“…Six children with neuroblastoma and one with ganglioneuroma received [125I] metaiodobenzylguanidine (MIBG) before major surgery. Uptake of [125I]MIBG in the…”
Get full text
Journal Article -
11
The stability and distribution of Tc-HIDA in vivo and in vitro
Published in European Journal of Nuclear Medicine (01-10-1979)“…Tc-HIDA is a promising new agent for imaging the biliary system. In this study radiochromatography on paper or Sephadex G25 gel has been used to measure the…”
Get full text
Journal Article -
12
High-dose methylprednisolone sodium succinate as a single agent in relapsed childhood acute lymphoblastic leukaemia
Published in Medical and pediatric oncology (1992)“…Twenty children received methylprednisolone (1 g/m2), daily for 5 to 8 days, as initial single agent therapy for relapsed acute lymphoblastic leukaemia. Bone…”
Get more information
Journal Article